Effective strategies for long-term statin use

被引:26
作者
Fonarow, GC [1 ]
Watson, KE [1 ]
机构
[1] Univ Calif Los Angeles, Prevent Cardiol Program, Div Cardiol, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/S0002-9149(03)00506-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Long-term statin use achieves a significant reduction in mortality (24% to 42%) for patients with coronary artery disease (CAD) that is equal to or greater than that seen with other secondary prevention medications, including aspirin, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. In patients with diabetes, the reduction in mortality exceeds that seen with tight glycemic control or any other treatment for diabetes. Several studies have found that almost all patients with atherosclerosis are considered candidates for statin treatment. The scientific evidence needed to revise the national guidelines has been provided by showing that initiation of statins before hospital discharge results in (1) a marked increase in long-term treatment rates, (2) improved long-term patient compliance, (3) more patients reaching levels of low-density lipoprotein (LDL) cholesterol < 100 mg/dL, and (4) improved clinical outcome. Nonetheless, many studies in a variety of clinical settings have demonstrated that, regardless of the health care delivery system, an unacceptable number of patients with atherosclerosis are left untreated or undertreated with statin therapy. Applying hospital-based systems has been demonstrated to address the problems of underuse. The national guidelines now recommend that, in addition to diet and exercise counseling, lipid-lowering medications be initiated before hospital discharge for patients diagnosed with cardiovascular disease. Optimal use of statins and other cardioprotective medications in high-risk patients could save >83,000 lives per year in the United States. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码:27I / 34I
页数:8
相关论文
共 45 条
[1]  
*AM HEART ASS, 2002, 2003 HEART STROK STA
[2]   DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS [J].
ANDRADE, SE ;
WALKER, AM ;
GOTTLIEB, LK ;
HOLLENBERG, NK ;
TESTA, MA ;
SAPERIA, GM ;
PLATT, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) :1125-1131
[3]   Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study [J].
Aronow, HD ;
Topol, EJ ;
Roe, MT ;
Houghtaling, PL ;
Wolski, KE ;
Lincoff, AM ;
Harrington, RA ;
Califf, RM ;
Ohman, EM ;
Kleiman, NS ;
Keltai, M ;
Wilcox, RG ;
Vahanian, A ;
Armstrong, PW ;
Lauer, MS .
LANCET, 2001, 357 (9262) :1063-1068
[4]  
Birtcher KK, 2000, AM J CARDIOL, V85, p30A
[5]   TREATMENT OF HYPERCHOLESTEROLEMIA BY A CLINICAL NURSE USING A STEPPED-CARE PROTOCOL IN A NONVOLUNTEER POPULATION [J].
BLAIR, TP ;
BRYANT, FJ ;
BOCUZZI, S .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (05) :1046-1048
[6]  
Braunwald E, ACC AHA 2002 GUID UP
[7]   Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin [J].
Brown, AS ;
Bakker-Arkema, RG ;
Yellen, L ;
Henley, RW ;
Guthrie, R ;
Campbell, CF ;
Koren, M ;
Woo, W ;
McLain, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :665-672
[8]  
Cannon CP, 2001, J AM COLL CARDIOL, V37, p334S
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]  
Collins R, 2002, INT J CLIN PRACT, V56, P53